Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET

NuklearMedizin

Volumn 47, Issue 4, 2008, Pages 147-152

  Reuter, S ^a   Gruner B ^a   Buck, A K ^a   Blumstein, N ^a   Kern, Peter ^a   Reske, S N ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Disease activity; Echinococcus multilocularis; Imaging; Parasitostatic; Treatment

Indexed keywords

BENZIMIDAZOLE; FLUORODEOXYGLUCOSE F 18; IOPROMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LUNG HYDATID CYST; MALE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE;

ECHINOCOCCOSIS, PULMONARY; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 49449083542     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0139     Document Type: Article

References (20)

1. Ammann RW, Eckert J. Cestodes. Echinococcus. Gastroenterol Clin North Am 1996; 25: 655-689.
2. Ammann RW, Hirsbrunner R, Cotting J et al. Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am J Trop Med Hyg 1990; 43: 506-515.
3. Ammann RW, Renner EC, Gottstein B et al. Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001). J Hepatol 2004; 41: 551-559.
4. Ammann, RW, Ilitsch N, Marincek B et al. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Swiss Echinococcosis Study Group. Hepatology 1994; 19: 735-742.
5. Bresson-Hadni S, Delabrousse E, Blagosklonov O et al. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int 2006; 55 (Suppl): S267-S272.
6. Craig P. Echinococcus multilocularis. Curr Opin Infect Dis 2003; 16: 437-444.
7. Dreweck CM, Luder CG, Soboslay PT et al. Subclass-specific serological reactivity and IgG4-specific antigen recognition in human echinococcosis. Trop Med Int Health 1997; 2: 779-787.
8. Flamen P, Hoekstra OS, Homans F et al. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer 2001; 37: 862-869.
9. Fujimoto Y, Ito A, Ishikawa Y et al. Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis. J Gastroenterol 2005: 40: 426-431.
10. Gottstein B, Haag K, Walker M et al. Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol.Int. 2006; 55 (Suppl): S45-S49.
11. Ishizu H, Uchino J, Sato N et al. Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology 1997; 25: 528-531.
12. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006; 354: 496-507.
13. 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002; 43: 492-499.
14. Kern P, Ammon A, Kron M et al. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis 2004; 10: 2088-2093.
15. Kern P. Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). Parasitol Int 2006; 55 (Suppl): S273-S282.
16. Reuter S, Buck A, Manfras B et al. Structured Treatment Interruption in Patients With Alveolar Echinococcosis. Hepatology 2004; 39: 509-517.
17. Reuter S, Jensen B, Buttenschoen K et al. Benzimidazoles in the treatment of alveolar echinococcosis: A comparative study and review of the literature. J Antimicrob Chemother 2000; 46: 451-456.
18. Reuter S, Schirrmeister H, Kratzer W et al. Pericystic metabolic activity in alveolar echinococcosis: Assessment and follow-up by positron-emission- tomography (PET). Clin Infect Dis 1999; 29: 1157-1163.
19. 18F- fluorodeoxyglucose (FDG) positron-emission-tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 2007; 35: 11-18.
20. Wen H, Bresson-Hadni S, Vuitton DA et al. Analysis of immunoglobulin G subclass in the serum antibody responses of alveolar echinococcosis patients after surgical treatment and chemotherapy as an aid to assessing the outcome. Trans R Soc Trop Med Hyg 1995; 89: 692-697.